Prabhakaran Shyam, Cox Margueritte, Lytle Barbara, Schulte Phillip J, Xian Ying, Zahuranec Darin, Smith Eric E, Reeves Mathew, Fonarow Gregg C, Schwamm Lee H
Feinberg School of Medicine (SP), Northwestern University, Chicago, IL; Duke Clinical Research Institute (MC, BL, PJS, YX), Durham, NC; University of Michigan (DZ), Ann Arbor; Hotchkiss Brain Institute (EES), University of Calgary, Canada; Michigan State University (MR), East Lansing; Ahmanson Cardiomyopathy Center (GCF), UCLA, Los Angeles, CA; Stroke Service (LHS), Massachusetts General Hospital, Boston; and Duke University Medical Center (YX), Durham, NC.
Neurol Clin Pract. 2017 Jun;7(3):194-204. doi: 10.1212/CPJ.0000000000000358.
Death after acute stroke often occurs after forgoing life-sustaining interventions. We sought to determine the patient and hospital characteristics associated with an early decision to transition to comfort measures only (CMO) after ischemic stroke (IS), intracerebral hemorrhage (ICH), and subarachnoid hemorrhage (SAH) in the Get With The Guidelines-Stroke registry.
We identified patients with IS, ICH, or SAH between November 2009 and September 2013 who met study criteria. Early CMO was defined as the withdrawal of life-sustaining treatments and interventions by hospital day 0 or 1. Using multivariable logistic regression, we identified patient and hospital factors associated with an early (by hospital day 0 or 1) CMO order.
Among 963,525 patients from 1,675 hospitals, 54,794 (5.6%) had an early CMO order (IS: 3.0%; ICH: 19.4%; SAH: 13.1%). Early CMO use varied widely by hospital (range 0.6%-37.6% overall) and declined over time (from 6.1% in 2009 to 5.4% in 2013; < 0.001). In multivariable analysis, older age, female sex, white race, Medicaid and self-pay/no insurance, arrival by ambulance, arrival off-hours, baseline nonambulatory status, and stroke type were independently associated with early CMO use (vs no early CMO). The correlation between hospital-level risk-adjusted mortality and the use of early CMO was stronger for SAH ( = 0.52) and ICH ( = 0.50) than AIS ( = 0.15) patients.
Early CMO was utilized in about 5% of stroke patients, being more common in ICH and SAH than IS. Early CMO use varies widely between hospitals and is influenced by patient and hospital characteristics.
急性卒中后的死亡通常发生在放弃维持生命的干预措施之后。我们试图在“遵循卒中指南”注册研究中确定与缺血性卒中(IS)、脑出血(ICH)和蛛网膜下腔出血(SAH)后早期决定仅过渡到舒适治疗措施(CMO)相关的患者和医院特征。
我们确定了2009年11月至2013年9月期间符合研究标准的IS、ICH或SAH患者。早期CMO被定义为在住院第0天或第1天停止维持生命的治疗和干预措施。使用多变量逻辑回归,我们确定了与早期(住院第0天或第1天)CMO医嘱相关的患者和医院因素。
在来自1675家医院的963525例患者中,54794例(5.6%)有早期CMO医嘱(IS:3.0%;ICH:19.4%;SAH:13.1%)。早期CMO的使用在不同医院之间差异很大(总体范围为0.6% - 37.6%),并且随时间下降(从2009年的6.1%降至2013年的5.4%;P<0.001)。在多变量分析中,年龄较大、女性、白人种族、医疗补助和自费/无保险、救护车送达、非工作时间到达、基线非步行状态和卒中类型与早期CMO的使用独立相关(与无早期CMO相比)。与急性缺血性卒中(AIS)患者相比,医院层面风险调整后的死亡率与SAH(r = 0.52)和ICH(r = 0.50)患者早期CMO使用之间的相关性更强。
约5%的卒中患者采用了早期CMO,在ICH和SAH中比IS更常见。早期CMO的使用在不同医院之间差异很大,并受患者和医院特征的影响。